CTLA4 and Alzheimer disease: Moreover, miR-155 has been identified as overexpressed in skin from AD patients compared to healthy controls, and by downregulating cytotoxic T lymphocyte-associated antigen (CTLA)-4, a negative regulator of T-cell function, miR-155 could influence the development of AD [20,21].